Nitemazepam

Nitemazepam (or 3-hydroxynimetazepam) is a benzodiazepine derivative which was first synthesised in the 1970s but was never marketed. It is the 3-hydroxy derivative of nimetazepam, and an active metabolite. It is also the 7-nitro instead of 7-chloro analogue of temazepam. It has in more recent years been sold as a designer drug, first being definitively identified in Europe in 2017.[1][2]

Not to be confused with nitrazepam or nimetazepam.
Nitemazepam
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC16H14N3O4
Molar mass312.305 g·mol−1
3D model (JSmol)

See also

References
  1. Zawilska JB, Wojcieszak J. An expanding world of New Psychoactive Substances – Designer benzodiazepines. NeuroToxicology 2019 July; 73: 8-16. doi:10.1016/j.neuro.2019.02.015
  2. Moosmann B., Auwärter V. (2018) Designer Benzodiazepines: Another Class of New Psychoactive Substances. In: Maurer H., Brandt S. (eds) New Psychoactive Substances. Handbook of Experimental Pharmacology, vol 252. doi:10.1007/164_2018_154
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.